Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maj

Showing results (131-140 of 261) with videos related to

Pageof 27
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1990
Factors associated with increased noradrenaline levels in schizophrenic patientsD Kemali, M Maj, S Galderisi, et al.
Advances in Biochemical Psychopharmacology|January 1, 1985
Response to lithium prophylaxis in schizoaffective psychosesD Kemali, M Maj, M G Ariano, et al.
Psychoneuroendocrinology|January 1, 1995
Plasma melatonin and cortisol circadian patterns in patients with obsessive-compulsive disorder before and after fluoxetine treatmentP Monteleone, F Catapano, A Tortorella, et al.
Polish Journal of Pharmacology|May 3, 2002
Expression of proenkephalin (PENK) mRNA in inflammatory leukocytes during experimental peritonitis in Swiss miceM Chadzinska, M Maj, A Scislowska-Czarnecka, et al.
Neuropsychobiology|January 1, 1985
24-hour plasma levels of prolactin, cortisol, growth hormone and catecholamines in schizophrenic patientsD Kemali, M Maj, M G Ariano, et al.
Neuropsychobiology|January 1, 1996
Influence of moclobemide on cognitive functions of nine depressed patients: pilot trial with neurophysiological and neuropsychological indicesS Galderisi, A Mucci, P Bucci, et al.
Journal of Affective Disorders|March 10, 2000
Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: preliminary dataM Maj, R Pirozzi, A M Formicola, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1995
Neuropsychological slowness in obsessive-compulsive patients. Is it confined to tests involving the fronto-subcortical systems?S Galderisi, A Mucci, F Catapano, et al.
Schizophrenia Research|December 1, 1991
CEEG mapping in drug-free schizophrenics. Differences from healthy subjects and changes induced by haloperidol treatmentS Galderisi, A Mucci, M L Mignone, et al.
Biochimica Et Biophysica Acta|December 5, 1996
Reaction of E. coli catalase HPII with cyanide as ligand and as inhibitorM Maj, P Nicholls, C Obinger, et al.
Pageof 27

Showing results (131-140 of 261) with videos related to

Sort By:
Pageof 27
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1990
Factors associated with increased noradrenaline levels in schizophrenic patientsD Kemali, M Maj, S Galderisi, et al.
Advances in Biochemical Psychopharmacology|January 1, 1985
Response to lithium prophylaxis in schizoaffective psychosesD Kemali, M Maj, M G Ariano, et al.
Psychoneuroendocrinology|January 1, 1995
Plasma melatonin and cortisol circadian patterns in patients with obsessive-compulsive disorder before and after fluoxetine treatmentP Monteleone, F Catapano, A Tortorella, et al.
Polish Journal of Pharmacology|May 3, 2002
Expression of proenkephalin (PENK) mRNA in inflammatory leukocytes during experimental peritonitis in Swiss miceM Chadzinska, M Maj, A Scislowska-Czarnecka, et al.
Neuropsychobiology|January 1, 1985
24-hour plasma levels of prolactin, cortisol, growth hormone and catecholamines in schizophrenic patientsD Kemali, M Maj, M G Ariano, et al.
Neuropsychobiology|January 1, 1996
Influence of moclobemide on cognitive functions of nine depressed patients: pilot trial with neurophysiological and neuropsychological indicesS Galderisi, A Mucci, P Bucci, et al.
Journal of Affective Disorders|March 10, 2000
Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: preliminary dataM Maj, R Pirozzi, A M Formicola, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1995
Neuropsychological slowness in obsessive-compulsive patients. Is it confined to tests involving the fronto-subcortical systems?S Galderisi, A Mucci, F Catapano, et al.
Schizophrenia Research|December 1, 1991
CEEG mapping in drug-free schizophrenics. Differences from healthy subjects and changes induced by haloperidol treatmentS Galderisi, A Mucci, M L Mignone, et al.
Biochimica Et Biophysica Acta|December 5, 1996
Reaction of E. coli catalase HPII with cyanide as ligand and as inhibitorM Maj, P Nicholls, C Obinger, et al.
Pageof 27